GREY:ATBPF - Post by User
Comment by
Jefferam1on Sep 05, 2018 9:56am
138 Views
Post# 28564669
RE:ANTIBE LONGs rewarded for patience!
RE:ANTIBE LONGs rewarded for patience!SergeantSanderz wrote: - The $13 mil upfront along with leftover cash (after completion of FINAL Phase 2, parts 1 and 2) and some incoming cash from the last warrants may add up to be enough money to fully fund Phase 3. WOW! A strong place to be in! We may be ready for our SK partner to commence sales by late 2020!
Hold the horses SergeantSanders,
Don't get me wrong this is great news but you post is missleading (hopefully no intentionally).
1.3 Million upfront (not 13 Million).
$13 million in non-dilutive development and commercial milestone payments That means there will be milestone payments which will include payments in Phase 3 and comercialization so they are not getting the full 13 million till then and probably the majority of it will be in the later phases.
Plus Antibe will have to do 2 Phase 3 trials which will be 10-25 Million each (I'm guessing here, don't have the numbers but they are expensive). Antibe does not and will not have the money for Phase 3. But in the end that doesn't matter, there business plan is to partner prior to Phase 3. So they don't need the money to get there. All they need is the money to get to the end of phase 2 trials and probably another 12 months after to buy time for partnership. This deal should get them near that now and with the milestone payments probably does get them there.
This might give them the money to speedup the pipepline drugs too. And if citagenix stops the bleeding and gets even cashflow this is shaping up nicely.